Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

JUERGENS

Showing results (611-620 of 662) with videos related to

Pageof 67
Sort By:
Nature|April 29, 2026
The past, present and future of de novo protein designWei Yang, Shunzhi Wang, Gyu Rie Lee, et al.
European Journal of Cancer (Oxford, England : 1990)|August 18, 2023
Association between local treatment modalities and event-free survival, overall survival, and local recurrence in patients with localised Ewing Sarcoma. Report from the Ewing 2008 trialPhilip Heesen, Andreas Ranft, Vivek Bhadri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2011
R1507, a monoclonal antibody to the insulin-like growth factor 1 receptor, in patients with recurrent or refractory Ewing sarcoma family of tumors: results of a phase II Sarcoma Alliance for Research through Collaboration studyAlberto S Pappo, Shreyaskumar R Patel, John Crowley, et al.
European Journal of Cancer (Oxford, England : 1990)|May 30, 2026
Treatment effect heterogeneity of radiotherapy in localized Ewing sarcoma: A secondary analysis of the EURO-E.W.I.N.G. 99 and Ewing 2008 trialPhilip Heesen, Stefan Feuerriegel, Olga Ciobanu-Caraus, et al.
European Journal of Cancer (Oxford, England : 1990)|July 20, 2024
Impact of age on safety of Busulfan-Melphalan followed by autologous hematopoietic stem-cell transplantation versus standard chemotherapy in the patients of the EURO-E.W.I.N.G. 99 and Ewing 2008 clinical trialsXavier Choderlos de Laclos, Séverine Risbourg, Bernadette Brennan, et al.
Research Square|February 27, 2026
Duration of Initial Viremia Modulates Functional Properties of HIV-specific T Cell ReceptorsBruce Walker, Funsho Ogunshola, Nishant Singh, et al.
Therapeutic Advances in Medical Oncology|August 4, 2022
The economic value of liquid biopsy for genomic profiling in advanced non-small cell lung cancerDoreen A Ezeife, Eldon Spackman, Rosalyn A Juergens, et al.
Circulation|May 9, 2022
Text Messages to Improve Medication Adherence and Secondary Prevention After Acute Coronary Syndrome: The TEXTMEDS Randomized Clinical TrialClara K Chow, Harry Klimis, Aravinda Thiagalingam, et al.
The Pediatric Infectious Disease Journal|January 5, 2023
Incidence Rates of Medically Attended COVID-19 in Infants Less Than 6 Months of AgeIsabel Griffin, Stephanie A Irving, Carmen Sofia Arriola, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 21, 2012
Long-term outcomes of hematopoietic stem cell transplantation for severe treatment-resistant autoimmune cytopenia in childrenMarco Rabusin, J A Snowden, Paul Veys, et al.
Pageof 67

Showing results (611-620 of 662) with videos related to

Sort By:
Pageof 67
Nature|April 29, 2026
The past, present and future of de novo protein designWei Yang, Shunzhi Wang, Gyu Rie Lee, et al.
European Journal of Cancer (Oxford, England : 1990)|August 18, 2023
Association between local treatment modalities and event-free survival, overall survival, and local recurrence in patients with localised Ewing Sarcoma. Report from the Ewing 2008 trialPhilip Heesen, Andreas Ranft, Vivek Bhadri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2011
R1507, a monoclonal antibody to the insulin-like growth factor 1 receptor, in patients with recurrent or refractory Ewing sarcoma family of tumors: results of a phase II Sarcoma Alliance for Research through Collaboration studyAlberto S Pappo, Shreyaskumar R Patel, John Crowley, et al.
European Journal of Cancer (Oxford, England : 1990)|May 30, 2026
Treatment effect heterogeneity of radiotherapy in localized Ewing sarcoma: A secondary analysis of the EURO-E.W.I.N.G. 99 and Ewing 2008 trialPhilip Heesen, Stefan Feuerriegel, Olga Ciobanu-Caraus, et al.
European Journal of Cancer (Oxford, England : 1990)|July 20, 2024
Impact of age on safety of Busulfan-Melphalan followed by autologous hematopoietic stem-cell transplantation versus standard chemotherapy in the patients of the EURO-E.W.I.N.G. 99 and Ewing 2008 clinical trialsXavier Choderlos de Laclos, Séverine Risbourg, Bernadette Brennan, et al.
Research Square|February 27, 2026
Duration of Initial Viremia Modulates Functional Properties of HIV-specific T Cell ReceptorsBruce Walker, Funsho Ogunshola, Nishant Singh, et al.
Therapeutic Advances in Medical Oncology|August 4, 2022
The economic value of liquid biopsy for genomic profiling in advanced non-small cell lung cancerDoreen A Ezeife, Eldon Spackman, Rosalyn A Juergens, et al.
Circulation|May 9, 2022
Text Messages to Improve Medication Adherence and Secondary Prevention After Acute Coronary Syndrome: The TEXTMEDS Randomized Clinical TrialClara K Chow, Harry Klimis, Aravinda Thiagalingam, et al.
The Pediatric Infectious Disease Journal|January 5, 2023
Incidence Rates of Medically Attended COVID-19 in Infants Less Than 6 Months of AgeIsabel Griffin, Stephanie A Irving, Carmen Sofia Arriola, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 21, 2012
Long-term outcomes of hematopoietic stem cell transplantation for severe treatment-resistant autoimmune cytopenia in childrenMarco Rabusin, J A Snowden, Paul Veys, et al.
Pageof 67